Suma P. Shankar
Research Subjects
Suma P. Shankar has a total of 439 co-authors. Here are the top co-authors by number of shared publications:
Alena Egense
MIND Institute University of California Davis Sacramento California USA
3 shared publicationsRong Mao
ARUP Labs, Mol Genet & Genom, Salt Lake City, UT USA
3 shared publications- Arunkanth Ankala
Department of Human Genetics, Emory University, Atlanta, GA, USA
2 shared publications Baker Hubbard
Department of Ophthalmology Emory University Atlanta Georgia
2 shared publicationsJohn J. Alexander
Department of Human Genetics Emory University School of Medicine Atlanta Georgia
2 shared publicationsKatherine A. Rauen
Division of Genomic Medicine, UC Davis MIND Institute, Department of Pediatrics, University of California, Davis, Sacramento, CA
2 shared publications
Latest Publications
- Open Access
De novo variants in KDM2A cause a syndromic neurodevelopmental disorder
Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo variants in KDM2A , a lysine demethylase crucial for embryonic development, in 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe intellectual disability. Other core symptoms included feeding difficulties, growth issues such as intrauterine growth restriction, short stature and microcephaly as well as recurrent facial features like epicanthic folds, upslanted palpebral fissures, thin lips, and low-set ears. Expression of human disease-causing KDM2A variants in a Drosophila melanogaster model led to neural degeneration, motor defects, and reduced lifespan. Interestingly, pathogenic variants in KDM2A affected physiological attributes including subcellular distribution, expression and stability in human cells. Genetic epistasis experiments indicated that KDM2A variants likely exert their effects through a potential gain-of-function mechanism, as eliminating endogenous KDM2A in Drosophila did not produce noticeable neurodevelopmental phenotypes. Data from Enzymatic-Methylation sequencing supports the suggested gene-disease association by showing an aberrant methylome profiles in affected individuals’ peripheral blood. Combining our genetic, phenotypic and functional findings, we establish de novo variants in KDM2A as causative for a syndromic neurodevelopmental disorder.
Open AccessDe novo variants in KDM2A cause a syndromic neurodevelopmental disorder
Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo variants in KDM2A , a lysine demethylase crucial for embryonic development, in 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe intellectual disability. Other core symptoms included feeding difficulties, growth issues such as intrauterine growth restriction, short stature and microcephaly as well as recurrent facial features like epicanthic folds, upslanted palpebral fissures, thin lips, and low-set ears. Expression of human disease-causing KDM2A variants in a Drosophila melanogaster model led to neural degeneration, motor defects, and reduced lifespan. Interestingly, pathogenic variants in KDM2A affected physiological attributes including subcellular distribution, expression and stability in human cells. Genetic epistasis experiments indicated that KDM2A variants likely exert their effects through a potential gain-of-function mechanism, as eliminating endogenous KDM2A in Drosophila did not produce noticeable neurodevelopmental phenotypes. Data from Enzymatic-Methylation sequencing supports the suggested gene-disease association by showing an aberrant methylome profiles in affected individuals’ peripheral blood. Combining our genetic, phenotypic and functional findings, we establish de novo variants in KDM2A as causative for a syndromic neurodevelopmental disorder.
- 30 November 2024
- Published by Springer Nature
- p. 679-706
Ophthalmic Manifestations in RASopathies
- Open Access
- 1 January 2023
- Published by Elsevier
- Vol. 16, 41-52
Prader-Willi and Angelman Syndromes: Mechanisms and Management
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are genetic imprinting disorders resulting from absent or reduced expression of paternal or maternal genes in chromosome 15q11q13 region, respectively. The most common etiology is deletion of the maternal or paternal 15q11q13 region. Methylation is the first line for molecular diagnostic testing; MS-MLPA is the most sensitive test. The molecular subtype of PWS/AS provides more accurate recurrence risk information for parents and for the individual affected with the condition. Management should include a multidisciplinary team by various medical subspecialists and therapists. Developmental and behavioral management of PWS and AS in infancy and early childhood includes early intervention services and individualized education programs for school-aged children. Here, we compare and discuss the mechanisms, pathophy-siology, clinical features, and management of the two imprinting disorders, PWS and AS.
- 1 January 2023
- Published by Elsevier
- Vol. 16, 41-52
Open AccessPrader-Willi and Angelman Syndromes: Mechanisms and Management
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are genetic imprinting disorders resulting from absent or reduced expression of paternal or maternal genes in chromosome 15q11q13 region, respectively. The most common etiology is deletion of the maternal or paternal 15q11q13 region. Methylation is the first line for molecular diagnostic testing; MS-MLPA is the most sensitive test. The molecular subtype of PWS/AS provides more accurate recurrence risk information for parents and for the individual affected with the condition. Management should include a multidisciplinary team by various medical subspecialists and therapists. Developmental and behavioral management of PWS and AS in infancy and early childhood includes early intervention services and individualized education programs for school-aged children. Here, we compare and discuss the mechanisms, pathophy-siology, clinical features, and management of the two imprinting disorders, PWS and AS.
- Open Access
- 4 August 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (10) , e2018
Atypical presentation of Angelman syndrome with intact expressive language due to low‐level mosaicism
Background: Angelman syndrome (AS) occurs due to a lack of expression or function of the maternally inherited UBE3A gene. Individuals with AS typically have significant developmental delay, severe speech impairment with absent to minimal verbal language, gait abnormalities including ataxia, and an incongruous happy demeanor. The majority of individuals with AS also have seizures and microcephaly. Some individuals with mosaic AS have been reported to have expressive language and milder levels of developmental delay.Case Report: We report a male patient presenting with mild to moderate intellectual disability, hyperphagia, obesity, and the ability to communicate verbally. His phenotype was suggestive of Prader‐Willi syndrome. However, methylation testing was positive for Angelman syndrome and additional methylation specific multiplex ligation‐dependent amplification (MS‐MLPA) study revealed low‐level mosaicism for AS.Conclusion: A broader phenotypic spectrum should be considered for AS as patients with atypical presentations may otherwise elude diagnosis.
- 4 August 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 10 (10) , e2018
Open AccessAtypical presentation of Angelman syndrome with intact expressive language due to low‐level mosaicism
Background: Angelman syndrome (AS) occurs due to a lack of expression or function of the maternally inherited UBE3A gene. Individuals with AS typically have significant developmental delay, severe speech impairment with absent to minimal verbal language, gait abnormalities including ataxia, and an incongruous happy demeanor. The majority of individuals with AS also have seizures and microcephaly. Some individuals with mosaic AS have been reported to have expressive language and milder levels of developmental delay.Case Report: We report a male patient presenting with mild to moderate intellectual disability, hyperphagia, obesity, and the ability to communicate verbally. His phenotype was suggestive of Prader‐Willi syndrome. However, methylation testing was positive for Angelman syndrome and additional methylation specific multiplex ligation‐dependent amplification (MS‐MLPA) study revealed low‐level mosaicism for AS.Conclusion: A broader phenotypic spectrum should be considered for AS as patients with atypical presentations may otherwise elude diagnosis.
- Open Access
- 11 June 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 27, 101613
Retinal dystrophies: A look beyond the eyes
- 11 June 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 27, 101613
Open AccessRetinal dystrophies: A look beyond the eyes
- Open Access
- 28 April 2022
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (7) , 1567-1582
A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder
- 28 April 2022
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (7) , 1567-1582
Open AccessA novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder
- 7 January 2022
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 135 (2) , 122-132
Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I
- 7 January 2022
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 135 (2) , 122-132
Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I
- 6 October 2021
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 43 (1) , 48-57
Ophthalmic manifestations in Costello syndrome caused by Ras pathway dysregulation during development
Costello syndrome (CS) is a multisystem developmental disorder caused by germline pathogenic variants in HRAS resulting in dysregulation of the Ras pathway. A systematic characterization of ophthal...
- 6 October 2021
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 43 (1) , 48-57
Ophthalmic manifestations in Costello syndrome caused by Ras pathway dysregulation during development
Costello syndrome (CS) is a multisystem developmental disorder caused by germline pathogenic variants in HRAS resulting in dysregulation of the Ras pathway. A systematic characterization of ophthal...
- 12 January 2021
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 42 (2) , 110-113
The evolving role of genetics in ophthalmology
Advances in molecular genetics over the past three decades have helped identify a substantial number of genetic variants causing inherited eye diseases that can be identified rapidly by appropriate genetic tests in a clinically useful window. With this progression of knowledge, the roles of genetics and ophthalmology in patient care have become increasingly intertwined, and the necessity for subspecialists in the field of ophthalmic genetics is of paramount importance. As a result of continual medical specialization, technological progress in genetics and knowledge garnered by over a century and a half of cataloguing eye pathology, ophthalmic genetics has become an emerging subspecialty within ophthalmology. By virtue of its rapidly changing advances, genetics and genomics serves a large role within ophthalmology, and subspecialists with the same level of detailed and broad knowledge as any other ophthalmology subspecialty are now required in order to meet the growing needs of the expanding population.
- 12 January 2021
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 42 (2) , 110-113
The evolving role of genetics in ophthalmology
Advances in molecular genetics over the past three decades have helped identify a substantial number of genetic variants causing inherited eye diseases that can be identified rapidly by appropriate genetic tests in a clinically useful window. With this progression of knowledge, the roles of genetics and ophthalmology in patient care have become increasingly intertwined, and the necessity for subspecialists in the field of ophthalmic genetics is of paramount importance. As a result of continual medical specialization, technological progress in genetics and knowledge garnered by over a century and a half of cataloguing eye pathology, ophthalmic genetics has become an emerging subspecialty within ophthalmology. By virtue of its rapidly changing advances, genetics and genomics serves a large role within ophthalmology, and subspecialists with the same level of detailed and broad knowledge as any other ophthalmology subspecialty are now required in order to meet the growing needs of the expanding population.
- 1 November 2019
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 56 (6) , e45-e48
Ectopia Lentis et Pupillae Caused by ADAMTSL4 Pathogenic Variants and an Algorithm for Work-up
Ectopia lentis is displacement of the lens from its original position. It can be inherited or acquired with isolated or systemic findings. The authors describe a 4-year-old girl with isolated ectopia lentis et pupillae caused by pathogenic variants in the ADAMTSL4 gene and discuss the molecular genetic work-up of individuals with ectopia lentis. [ J Pediatr Ophthalmol Strabismus . 2019;56:e45–e48.]
- 1 November 2019
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 56 (6) , e45-e48
Ectopia Lentis et Pupillae Caused by ADAMTSL4 Pathogenic Variants and an Algorithm for Work-up
Ectopia lentis is displacement of the lens from its original position. It can be inherited or acquired with isolated or systemic findings. The authors describe a 4-year-old girl with isolated ectopia lentis et pupillae caused by pathogenic variants in the ADAMTSL4 gene and discuss the molecular genetic work-up of individuals with ectopia lentis. [ J Pediatr Ophthalmol Strabismus . 2019;56:e45–e48.]